Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...

SAN FRANCISCO, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- The National Psoriasis Foundation (NPF) is ...

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...

Risankizumab improved visible psoriasis and reduced subclinical vascular inflammation on optical coherence tomography over 52 ...

Knowing your psoriasis triggers can help you better manage your symptoms. Get psoriasis treatment strategies to improve your quality of life.

The National Psoriasis Foundation issued a new position statement that clarifies the definition of psoriasis disease severity ...

Learn about psoriasis treatment costs, from affordable steroids to costly biologics.

Assessing disease severity in younger patients remains complex because adult scoring tools may underestimate the disease ...

Approximately 20% to 30% of all people who suffer from psoriasis also develop painful inflammation in their joints over time.

For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...

Alumis (ALMS) stock surged after two Phase 3 trial for its lead drug, envudeucitinib, succeeded against plaque psoriasis. Read more here, ...

Hormonal fluctuations during pregnancy can increase the risk of psoriasis in nearly 10–20 per cent of women, health experts ...